News|Articles|July 24, 2024
Accelerating Small Molecule Advancements: The Power of Collaboration Between CDMOs and Biotechs (July 2024)
Author(s)Lonza
The increasing number of breakthroughs in small molecule drug development are exciting, but corresponding workflows are complex and require much more tailored approaches to ensure successful upstream and downstream processing, drug approvals and commercialization.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
3
European Parliament Revamps Pharmaceutical Policy Framework
4
Tjoapack’s Advanced Packaging Expansion Aims to Meet Rising Demand
5
